All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Syndicated LoansInvestment Grade Loans

Credit Suisse underwriting loan for Galenica acquisition

Pharmaceutical 230x150

Credit Suisse is the sole underwriter of a bridge facility for Galenica's $1.53bn acquisition of US biopharmaceuticals firm Relypsa, the acquirer said on Thursday.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree